Richard J. Schmidt

Last updated

Richard J. Schmidt was an American former physician who was convicted by a Louisiana court in 1998 of attempted second degree murder for injecting his mistress, Janice Trahan, with HIV. The case marked the first time in forensic history that viral RNA was used to prove a link between two people with Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS) in a criminal trial. [1]

In 1994 Schmidt used a sample of blood taken from one of his HIV-positive patients to inject into his lover and former colleague, Janice Trahan, infecting her with HIV. Six months later Ms. Trahan, a nurse, was diagnosed with HIV. Convinced that Schmidt had infected her after a suspiciously fleeting late-night visit to give her a "Vitamin B" injection, [2] Ms. Trahan had her ex-husband and former sexual partners tested. All were shown to be negative for HIV—results which led Lafayette, Louisiana police to further investigate her claims. [3]

HIV is a fairly fragile RNA virus, and lasts for only a few hours outside the human body. Detectives examining hospital records found that Schmidt had taken blood from one patient that night, but had never sent the blood to the lab. [4] The absence of laboratory testing identification references against this patient's name led to police visiting the man who readily disclosed that he had AIDS and that he had been called in for a blood test by Schmidt on the evening in question. The forensic challenge at that point was to match the RNA from the virus itself from the patient to the victim, a process known as strain analysis that had never been attempted before. HIV RNA was collected from the victim, from the putative patient source, and from thirty-two other unrelated, HIV-positive individuals living in the same metropolitan area. Scientists concluded that of all the samples they tested, the two viruses' RNA from the victim and the patient matched almost exactly, even with HIV's potential to mutate very rapidly. [5]

It was further disclosed at trial that the victim had also acquired Hepatitis C around the same time. [6] Evidence from Schmidt's patient records showed that a blood sample was taken from a patient with Hepatitis C the day before the HIV-infected sample was taken. The Hepatitis C sample was similarly not matched with any laboratory references - these two were the only such omissions found in Schmidt's patient records.

In 1998 Schmidt was sentenced to 50 years in prison for attempted second degree murder. [7]

In 2015, after 17 years served of his 50-year sentence, Schmidt was unanimously denied parole by the three-member State Board at a June hearing in Baton Rouge. [6]

On March, 3, 2023, the Louisiana Department of Public Safety & Corrections confirmed that Schmidt had died at a Baton Rouge hospital in Department of Corrections custody on February 12. Schmidt was 74. [8]

In media

Related Research Articles

<span class="mw-page-title-main">HIV</span> Human retrovirus, cause of AIDS

The human immunodeficiency viruses (HIV) are two species of Lentivirus that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype.

<span class="mw-page-title-main">Hepatitis C</span> Human viral infection

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis. During the initial infection period, people often have mild or no symptoms. Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. The virus persists in the liver, becoming chronic, in about 70% of those initially infected. Early on, chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.

Viral load, also known as viral burden, is a numerical expression of the quantity of virus in a given volume of fluid, including biological and environmental specimens. It is not to be confused with viral titre or viral titer, which depends on the assay. When an assay for measuring the infective virus particle is done, viral titre often refers to the concentration of infectious viral particles, which is different from the total viral particles. Viral load is measured using body fluids Sputum and blood plasma. As an example of environmental specimens, the viral load of norovirus can be determined from run-off water on garden produce. Norovirus has not only prolonged viral shedding and has the ability to survive in the environment but a minuscule infectious dose is required to produce infection in humans: less than 100 viral particles.

<span class="mw-page-title-main">Diagnosis of HIV/AIDS</span> Immunological test

HIV tests are used to detect the presence of the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA.

The spread of HIV/AIDS has affected millions of people worldwide; AIDS is considered a pandemic. The World Health Organization (WHO) estimated that in 2016 there were 36.7 million people worldwide living with HIV/AIDS, with 1.8 million new HIV infections per year and 1 million deaths due to AIDS. Misconceptions about HIV and AIDS arise from several different sources, from simple ignorance and misunderstandings about scientific knowledge regarding HIV infections and the cause of AIDS to misinformation propagated by individuals and groups with ideological stances that deny a causative relationship between HIV infection and the development of AIDS. Below is a list and explanations of some common misconceptions and their rebuttals.

Coinfection is the simultaneous infection of a host by multiple pathogen species. In virology, coinfection includes simultaneous infection of a single cell by two or more virus particles. An example is the coinfection of liver cells with hepatitis B virus and hepatitis D virus, which can arise incrementally by initial infection followed by superinfection.

GB virus C (GBV-C), formerly known as hepatitis G virus (HGV) and also known as human pegivirus – HPgV is a virus in the family Flaviviridae and a member of the Pegivirus, is known to infect humans, but is not known to cause human disease. Reportedly, HIV patients coinfected with GBV-C can survive longer than those without GBV-C, but the patients may be different in other ways. Research is active into the virus' effects on the immune system in patients coinfected with GBV-C and HIV.

<span class="mw-page-title-main">History of HIV/AIDS</span> Epidemiological history

AIDS is caused by a human immunodeficiency virus (HIV), which originated in non-human primates in Central and West Africa. While various sub-groups of the virus acquired human infectivity at different times, the present pandemic had its origins in the emergence of one specific strain – HIV-1 subgroup M – in Léopoldville in the Belgian Congo in the 1920s.

<span class="mw-page-title-main">HIV/AIDS in Taiwan</span> Overview of (typically) sexually transmitted disease in Taiwan

Taiwan's epidemic of HIV/AIDS began with the first case reported in December 1984. On 17 December 1990 the government promulgated the AIDS Prevention and Control Act. On 11 July 2007, the AIDS Prevention and Control Act was renamed the HIV Infection Control and Patient Rights Protection Act.

Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) co-infection is a multi-faceted, chronic condition that significantly impacts public health. According to the World Health Organization (WHO), 2 to 15% of those infected with HIV are also affected by HCV, increasing their risk of morbidity and mortality due to accelerated liver disease. The burden of co-infection is especially high in certain high-risk groups, such as intravenous drug users and men who have sex with men. These individuals who are HIV-positive are commonly co-infected with HCV due to shared routes of transmission including, but not limited to, exposure to HIV-positive blood, sexual intercourse, and passage of the Hepatitis C virus from mother to infant during childbirth.

Contaminated hemophilia blood products were a serious public health problem in the late 1970s up to 1985.

<span class="mw-page-title-main">HIV/AIDS in Russia</span>

The situation with the spread of HIV/AIDS in Russia is described by some researchers as an epidemic. The first cases of human immunodeficiency virus infection were recorded in the USSR in 1985-1987. Patient zero is officially considered to be a military interpreter who worked in Tanzania in the early 1980s and was infected by a local man during sexual contact. After 1988—1989 Elista HIV outbreak, the disease became known to the general public and the first AIDS centers were established. In 1995-1996, the virus spread among injecting drug users (IDUs) and soon expanded throughout the country. By 2006, HIV had spread beyond the vulnerable IDU group, endangering their heterosexual partners and potentially the entire population.

With less than 1 percent of the population estimated to be HIV-positive, Egypt is a low-HIV-prevalence country. However, between the years 2006 and 2011, HIV prevalence rates in Egypt increased tenfold. Until 2011, the average number of new cases of HIV in Egypt was 400 per year. But, in 2012 and 2013 it increased to about 600 new cases and in 2014 it reached 880 new cases per year. According to UNAIDS 2016 statistics, there are about 11,000 people currently living with HIV in Egypt. The Ministry of Health and Population reported in 2020 over 13,000 Egyptians are living with HIV/AIDS. However, unsafe behaviors among most-at-risk populations and limited condom usage among the general population place Egypt at risk of a broader epidemic.

A pin prick attack is an assault on another person with a needle or syringe tainted with the blood of somebody carrying a blood-borne disease, such as HIV. Although there have been numerous cases of people being attacked with needles and syringes, the idea that people infected with AIDS have deliberately attempted to infect others in this manner is generally considered an urban legend, real cases of infection of HIV in this manner were typically taken from infected victims rather than from infected attackers.

<span class="mw-page-title-main">Contaminated blood scandal in the United Kingdom</span> The historical contamination of blood products in the UK with HIV and hepatitis C virus

In the 1970s and 1980s, a large number of people – most of whom had haemophilia – were infected with hepatitis C and HIV, the virus that leads to acquired immune deficiency syndrome (AIDS), as a result of receiving contaminated clotting factor products. In the United Kingdom, these were supplied by the National Health Service (NHS) with many of the products being imported from the USA.

SAV001-H is the first candidate preventive HIV vaccine using a killed or "dead" version of the HIV-1 virus.

Infectious diseases within American correctional settings are a concern within the public health sector. The corrections population is susceptible to infectious diseases through exposure to blood and other bodily fluids, drug injection, poor health care, prison overcrowding, demographics, security issues, lack of community support for rehabilitation programs, and high-risk behaviors. The spread of infectious diseases, such as HIV and other sexually transmitted diseases, hepatitis C (HCV), hepatitis B (HBV), and tuberculosis, result largely from needle-sharing, drug use, and consensual and non-consensual sex among prisoners. HIV and hepatitis C need specific attention because of the specific public health concerns and issues they raise.

HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations: pregnancy, childbirth, and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention, and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC): In the United States and Puerto Rico between the years of 2014–2017, where prenatal care is generally accessible, there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.

Viviana Simon is a Professor of Microbiology at the Icahn School of Medicine at Mount Sinai (ISMMS). She is a member of the ISMMS Global Health and Emerging Pathogens Institute. Her research considers viral-host interactions and the mode of action of retroviral restriction factors. During the COVID-19 pandemic, Simon developed an antibody test that can determine immunity to Coronavirus disease 2019.

<i>HIV Haemophilia Litigation</i> Legal action by haemophiliacs infected with HIV through blood products

The HIV Haemophilia Litigation [1990] 41 BMLR 171, [1990] 140 NLJR 1349 (CA), [1989] E N. 2111, also known as AMcG002, and HHL, was a legal claim by 962 plaintiffs, mainly haemophiliacs, who were infected with HIV as a result of having been treated with blood products in the late 1970s and early 1980s. The first central defendants were the then Department of Health, with other defendants being the Licensing Authority of the time, (MCA), the CSM, the CBLA, and the regional health authorities of England and Wales. In total, there were 220 defendants in the action.

References

  1. ↑ Metzker, Michael L.; Mindell, David P; Liu, Xiao-Mei; Ptak, Roger G.; Gibbs, Richard A.; Hillis, David M (October 29, 2002). "Molecular evidence of HIV-1 transmission in a criminal case". Proceedings of the National Academy of Sciences . 99 (22): 14292–14297. Bibcode:2002PNAS...9914292M. doi: 10.1073/pnas.222522599 . PMC   137877 . PMID   12388776.
  2. ↑ "Scientists Use Virus to Trace Assault Suspect". ABC News. 7 January 2006. Retrieved 15 August 2017.
  3. ↑ Mindell, David (29 October 2002). "Molecular evidence of HIV-1 transmission in a criminal case". Proceedings of the National Academy of Sciences. 99 (22): 14292–14297. Bibcode:2002PNAS...9914292M. doi: 10.1073/pnas.222522599 . PMC   137877 . PMID   12388776.
  4. ↑ Lambert, Pam (24 May 1999). "Act of Revenge – Vol. 51 No. 19". PEOPLE.com. Time Inc. Retrieved 15 August 2017.
  5. ↑ Vogel, Gretchen (28 October 1998). "RNA Strain Analysis Debuts in Murder Trial". Science | AAAS. AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE. Retrieved 15 August 2017.
  6. 1 2 Burgess, Richard (15 June 2015). "State board denies parole to former Lafayette doctor convicted of injecting mistress with AIDS, hepatitis C". The Acadian Advocate . Archived from the original on 24 June 2018. Retrieved 15 August 2017.
  7. ↑ Dalke, Kate (2003-01-24). "In court, scientists map a murder weapon". Genome News Network . Retrieved 2016-11-16.
  8. ↑ "Dr. Richard Smidt has died". KATC. Retrieved 22 March 2023.
  9. ↑ Aquillano, Kate (14 March 2016). "'Forensic Files' follow-up: Doc who injected ex with HIV denied parole". HLNtv.com. Retrieved 15 August 2017.
  10. ↑ ""Forensic Files" Shot of Vengeance (TV Episode 2003)". imdb.com. 25 June 2003. Retrieved 15 August 2017.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.